Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000262 · ClinicalTrials.gov registry record · NA
Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00000262 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 20 participants.
The verdict
NCT00000262, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of combined sevoflurane and nitrous oxide inhalation on mood, psychomotor performance, and the pain response in humans.
Interventions
- OTHER Placebo
- DRUG 30% Nitrous oxide
- DRUG 0.4% Sevoflurane
- DRUG 0.2% sevoflurane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 1996-11 |
| Est. Completion | 1999-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000262
The ClinicalTrials.gov registry entry for NCT00000262 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00000262 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000262 about?
NCT00000262 is a clinical study titled "Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14". The purpose of this study is to determine the effects of combined sevoflurane and nitrous oxide inhalation on mood, psychomotor performance, and the pain response in humans.
What is the current status of trial NCT00000262?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 1996-11. Estimated completion is 1999-02.
What interventions are being tested in trial NCT00000262?
The interventions under investigation include: Placebo (OTHER), 30% Nitrous oxide (DRUG), 0.4% Sevoflurane (DRUG), 0.2% sevoflurane (DRUG).
Who is sponsoring clinical trial NCT00000262?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.